Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SGMO | AMGN | REGN | VRTX | GSK |
| Company | Sangamo Therapeutics | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.6179 | 306.42 | 984.04 | 451.90 | 45.42 |
| High | 0.6300 | 307.50 | 993.27 | 457.66 | 45.45 |
| Low | 0.5660 | 303.90 | 983.16 | 449.42 | 45.03 |
| Last | 0.5901 | 306.51 | 993.66 | 455.52 | 45.18 |
| Change | -0.0278 | +0.01 | +13.09 | +4.72 | +0.03 |
| % Change | -4.50% | unch | +1.33% | +1.05% | +0.07% |
| Volume | 703,773 | 503,675 | 88,080 | 356,503 | 956,178 |
| 20-Day Average Volume | 2,012,737 | 2,771,956 | 416,184 | 1,127,060 | 3,867,318 |
| Previous Close | 0.6179 | 306.50 | 980.57 | 450.80 | 45.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5665 | 303.28 | 961.79 | 424.49 | 44.27 |
| 20-Day Raw Stochastic | 49.48% | 70.47% | 95.58% | 97.56% | 81.91% |
| 20-Day Relative Strength | 49.96% | 58.38% | 61.72% | 74.07% | 62.13% |
| Weighted Alpha | -74.27 | +37.54 | +36.53 | +40.43 | +35.17 |
| Today's Opinion | 8% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 8% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 72% Sell | 8% Buy | 8% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.57% since 05/17/24 | -1.82% since 05/17/24 | +1.07% since 05/17/24 | +2.43% since 05/17/24 | +0.29% since 05/17/24 |
| Low | 0.5660 on 05/24/24 | 303.90 on 05/24/24 | 975.73 on 05/23/24 | 437.46 on 05/21/24 | 44.40 on 05/20/24 |
| High | 0.6859 on 05/20/24 | 316.67 on 05/21/24 | 997.87 on 05/22/24 | 457.66 on 05/24/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | +20.47% since 04/24/24 | +12.37% since 04/24/24 | +9.52% since 04/24/24 | +13.80% since 04/24/24 | +10.40% since 04/24/24 |
| Low | 0.4600 on 04/25/24 | 265.72 on 04/26/24 | 875.22 on 04/26/24 | 391.70 on 04/30/24 | 40.81 on 04/25/24 |
| High | 0.7000 on 05/17/24 | 322.60 on 05/03/24 | 997.87 on 05/22/24 | 457.66 on 05/24/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -47.44% since 02/23/24 | +6.08% since 02/23/24 | +1.18% since 02/23/24 | +6.03% since 02/23/24 | +6.85% since 02/23/24 |
| Low | 0.4600 on 04/25/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.15 on 04/18/24 |
| High | 1.3200 on 02/27/24 | 322.60 on 05/03/24 | 998.33 on 02/28/24 | 457.66 on 05/24/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +55.43% since 11/24/23 | +15.56% since 11/24/23 | +24.36% since 11/24/23 | +29.18% since 11/24/23 | +25.97% since 11/24/23 |
| Low | 0.3462 on 12/21/23 | 260.68 on 04/19/24 | 792.57 on 11/28/23 | 346.29 on 11/28/23 | 35.35 on 11/29/23 |
| High | 1.4800 on 02/16/24 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 457.66 on 05/24/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 128,220 | 164,417,328 | 108,045,080 | 116,330,288 | 93,570,672 |
| Shares Outstanding, K | 207,510 | 536,435 | 110,186 | 258,053 | 2,072,440 |
| Annual Sales | 176,230,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 37,725,000,000 |
| Annual Net Income | -257,830,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 6,129,940,000 |
| Last Quarter Sales | 480,000 | 7,447,000,000 | 3,145,000,000 | 2,690,600,000 | 9,337,020,000 |
| Last Quarter Net Income | -49,090,000 | -113,000,000 | 722,000,000 | 1,099,600,000 | 1,326,430,000 |
| 60-Month Beta | 1.40 | 0.60 | 0.17 | 0.39 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 05/09/24 | 3.96 on 05/02/24 | 9.55 on 05/02/24 | 4.76 on 05/06/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/02/24 | 05/06/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 26.51 | 29.72 | 11.33 |